AbbVie Inc.ABBV

Market cap

$417.4B

P/E ratio

	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenues	18,790	19,960	22,859	25,638	28,216	32,753	33,266	45,804	56,197	58,054	54,318	56,334
Cost of products sold	-	-	-	-	-	7,718	7,439	15,387	17,446	17,414	20,415	16,904
Selling, general and administrative	5,352	7,724	6,387	5,855	6,275	7,399	6,942	11,299	12,349	15,260	12,872	14,752
Research and development	2,855	3,297	4,285	4,366	4,982	10,329	6,407	6,557	7,084	6,510	7,675	12,791
Acquired IPR&D and milestones	338	352	150	200	327	424	385	1,200	962	697	778	2,800
Other operating expense (income), net	-	-	-	-	-	-	890	-	-432	-56	179	7
Total operating costs and expenses	13,126	16,549	15,322	16,254	18,624	26,370	20,283	34,441	38,273	39,937	41,561	47,197
Operating earnings	5,664	3,411	7,537	9,384	9,592	6,383	12,983	11,363	17,924	18,117	12,757	9,137
Interest expense, net	-278	-391	-686	-965	-1,004	-1,144	-1,509	-2,280	-2,384	-2,044	-1,684	-2,160
Net foreign exchange loss	-55	-678	-193	-303	-348	-24	-42	-71	-51	-148	-146	-21
Other expense, net	1	27	-13	-232	-513	-18	-3,006	-5,614	-2,500	-2,448	-4,677	-3,240
Earnings before income tax expense	-	-	-	-	-	-	-	-	12,989	13,477	6,250	3,716
Income tax expense (benefit)	1,204	595	1,501	1,931	2,418	-490	544	-1,224	1,440	1,632	1,377	-570
Net earnings	-	-	-	-	-	-	-	4,622	11,549	11,845	4,873	4,286
Net earnings attributable to noncontrolling interest	-	-	-	-	-	-	-	6	7	9	10	8
Net earnings attributable to AbbVie Inc.	-	-	-	5,953	5,309	5,687	7,882	4,622	11,549	11,845	4,873	4,286
Earnings Per Share, Basic	2.58	1.11	3.15	3.65	3.31	3.67	5.3	2.73	6.48	6.65	2.73	2.4
Earnings Per Share, Diluted	2.56	1.1	3.13	3.63	3.3	3.66	5.28	2.72	6.45	6.63	2.72	2.39